Standard Biotools (LAB) FCF Margin Growth (3y) (2013 - 2026)
Standard Biotools (LAB) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 119.95 Bn | 110.73 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 73.85 Bn | 73.31 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 52.69 Bn | 48.44 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 34.55 Bn | 32.60 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 34.11 Bn | 32.00 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.22 Bn | 22.73 Bn | 684.20 Mn | 60.00 |
| 10 | Standard Biotools | 256.97 Mn | -219.75 Mn | 10.54 Mn | -1,625.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,625.00 |
| Mar 31, 2026 | -18,407.00 |
| Dec 31, 2025 | 6,577.00 |
| Sep 30, 2025 | -1,242.00 |
| Jun 30, 2025 | 9,211.00 |
| Mar 31, 2025 | -11,265.00 |
| Sep 30, 2024 | -9,469.00 |
| Jun 30, 2024 | -10,956.00 |
| Mar 31, 2024 | -7,845.00 |
| Dec 31, 2023 | -775.00 |
| Sep 30, 2023 | -3,617.00 |
| Jun 30, 2023 | -2,358.00 |
| Mar 31, 2023 | -1,852.00 |
| Dec 31, 2022 | -5,523.00 |
| Sep 30, 2022 | -7,865.00 |
| Jun 30, 2022 | -14,544.00 |
| Mar 31, 2022 | 564.00 |
| Sep 30, 2021 | -3,929.00 |
| Jun 30, 2021 | -4,394.00 |
| Mar 31, 2021 | 392.00 |